Sichuan Huiyu Pharmaceutical Co., Ltd.
SSE:688553.SS
16.09 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 239.053 | 242.538 | 319.642 | 289.598 | 241.197 | 265.642 | 208.562 | 212.855 | 237.72 | 273.151 | 386.864 | 366.787 | 466.466 | 431.724 | 506.72 | 458.036 | 427.252 | 351.169 | 427.379 | 331.578 | 254.071 |
| Cost of Revenue
| 39.159 | 37.996 | 49.225 | 53.555 | 40.735 | 44.393 | 28.826 | 32.969 | 33.255 | 34.101 | 46.284 | 46.118 | 49.68 | 53.24 | 36.159 | 27.014 | 40.886 | 34.324 | 31.398 | 28.324 | 17.782 |
| Gross Profit
| 199.894 | 204.542 | 270.417 | 236.043 | 200.462 | 221.249 | 179.736 | 179.886 | 204.465 | 239.05 | 340.58 | 320.669 | 416.786 | 378.485 | 470.561 | 431.022 | 386.366 | 316.846 | 395.981 | 303.254 | 236.289 |
| Gross Profit Ratio
| 0.836 | 0.843 | 0.846 | 0.815 | 0.831 | 0.833 | 0.862 | 0.845 | 0.86 | 0.875 | 0.88 | 0.874 | 0.893 | 0.877 | 0.929 | 0.941 | 0.904 | 0.902 | 0.927 | 0.915 | 0.93 |
| Reseach & Development Expenses
| 61.857 | 102.702 | 77.244 | 82.272 | 65.507 | 77.503 | 88.462 | 84.402 | 84.139 | 94.464 | 91.024 | 102.772 | 67.933 | 79.423 | 59.031 | 65.838 | 43.919 | 27.147 | 28.708 | 19.514 | 13.405 |
| General & Administrative Expenses
| 22.138 | -31.099 | 45.694 | -10.541 | 20.08 | -28.162 | 41.47 | -7.199 | 18.015 | -25.929 | 39.063 | -5.743 | 15.082 | -9.741 | 29.828 | -3.412 | 13.435 | -26.542 | 33.589 | -5.912 | 17.486 |
| Selling & Marketing Expenses
| 93.561 | 61.986 | 142.815 | 110.186 | 94.804 | 102.022 | 83.668 | 78.571 | 96.86 | 145.813 | 187.943 | 177.429 | 227.869 | 232.488 | 264.698 | 221.49 | 182.079 | 197.955 | 239.84 | 158.43 | 116.917 |
| SG&A
| 115.699 | 30.886 | 188.509 | 99.645 | 116.5 | 124.275 | 125.138 | 71.371 | 114.875 | 119.885 | 227.007 | 171.686 | 242.951 | 222.747 | 294.526 | 218.077 | 195.515 | 171.413 | 273.429 | 152.518 | 134.402 |
| Other Expenses
| 66.158 | -33.061 | -174.72 | 0.57 | 1.817 | 0.21 | 2.673 | 1.158 | -9.368 | 49.203 | -23.411 | 21.321 | -2.709 | -0.987 | -0.008 | 0.035 | -0.095 | 1.008 | -0.46 | -0.895 | -1.198 |
| Operating Expenses
| 243.714 | 100.527 | 91.032 | 204.516 | 180.19 | 201.567 | 189.051 | 168.431 | 189.646 | 263.551 | 294.62 | 295.779 | 308.175 | 328.306 | 336.548 | 302.239 | 237.725 | 241.174 | 279.011 | 193.968 | 146.68 |
| Operating Income
| -43.82 | 104.015 | 179.385 | 32.96 | 20.272 | 19.682 | 11.161 | 24.721 | 27.477 | -5.462 | 67.41 | 48.478 | 125.022 | 59.428 | 139.574 | 129.583 | 150.171 | 81.656 | 116.693 | 111.417 | 88.236 |
| Operating Income Ratio
| -0.183 | 0.429 | 0.561 | 0.114 | 0.084 | 0.074 | 0.054 | 0.116 | 0.116 | -0.02 | 0.174 | 0.132 | 0.268 | 0.138 | 0.275 | 0.283 | 0.351 | 0.233 | 0.273 | 0.336 | 0.347 |
| Total Other Income Expenses Net
| 0.686 | -4.368 | -0.665 | 0.57 | 5.73 | -2.053 | 2.673 | 1.158 | 6.008 | 2.961 | 0.3 | -0.124 | -0.195 | -0.987 | -0.008 | 0.035 | -0.095 | 1.008 | -0.46 | -0.895 | -1.198 |
| Income Before Tax
| -43.134 | 99.646 | 178.719 | 33.53 | 37.803 | 58.879 | 13.835 | 25.879 | 33.485 | -2.5 | 67.71 | 48.354 | 124.828 | 58.441 | 139.565 | 129.617 | 150.076 | 82.664 | 116.233 | 110.522 | 87.038 |
| Income Before Tax Ratio
| -0.18 | 0.411 | 0.559 | 0.116 | 0.157 | 0.222 | 0.066 | 0.122 | 0.141 | -0.009 | 0.175 | 0.132 | 0.268 | 0.135 | 0.275 | 0.283 | 0.351 | 0.235 | 0.272 | 0.333 | 0.343 |
| Income Tax Expense
| -16.449 | 4.515 | 20.159 | 16.204 | -7.076 | 8.367 | -6.326 | -4.311 | -4.911 | -16.128 | 2.05 | -2.155 | 5.634 | -0.35 | 10.117 | 6.659 | 15.415 | 6.99 | 11.78 | 21.491 | 14.372 |
| Net Income
| -25.626 | 98.038 | 162.139 | 18.778 | 46.436 | 50.846 | 20.238 | 30.307 | 38.395 | 13.628 | 65.66 | 50.509 | 119.193 | 58.791 | 129.448 | 122.958 | 134.662 | 75.612 | 105.566 | 89.114 | 73.032 |
| Net Income Ratio
| -0.107 | 0.404 | 0.507 | 0.065 | 0.193 | 0.191 | 0.097 | 0.142 | 0.162 | 0.05 | 0.17 | 0.138 | 0.256 | 0.136 | 0.255 | 0.268 | 0.315 | 0.215 | 0.247 | 0.269 | 0.287 |
| EPS
| -0.06 | 0.231 | 0.38 | 0.044 | 0.11 | 0.12 | 0.048 | 0.072 | 0.091 | 0.032 | 0.16 | 0.12 | 0.28 | 0.14 | 0.36 | 0.34 | 0.37 | 0.21 | 0.29 | 0.24 | 0.2 |
| EPS Diluted
| -0.06 | 0.231 | 0.38 | 0.044 | 0.11 | 0.12 | 0.048 | 0.072 | 0.091 | 0.032 | 0.15 | 0.12 | 0.28 | 0.14 | 0.36 | 0.34 | 0.37 | 0.21 | 0.29 | 0.24 | 0.2 |
| EBITDA
| -41.337 | 102.061 | 181.711 | 36.648 | 60.462 | 36.29 | 31.543 | 43.253 | 35.346 | 13.03 | 82.885 | 60.201 | 136.696 | 58.716 | 140.097 | 132.317 | 151.94 | 95.222 | 116.442 | 112.142 | 88.32 |
| EBITDA Ratio
| -0.173 | 0.421 | 0.568 | 0.127 | 0.251 | 0.137 | 0.151 | 0.203 | 0.149 | 0.048 | 0.214 | 0.164 | 0.293 | 0.136 | 0.276 | 0.289 | 0.356 | 0.271 | 0.272 | 0.338 | 0.348 |